Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samples

The COVID-19 pandemic, which began in 2020 is testing economic resilience and surge capacity of healthcare providers worldwide. At the time of writing, positive detection of the SARS-CoV-2 virus remains the only method for diagnosing COVID-19 infection. Rapid upscaling of national SARS-CoV-2 genome...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical microbiology 2021-03, Vol.70 (3)
Hauptverfasser: Thompson, Jamie L, Downie Ruiz Velasco, Angela, Cardall, Alice, Tarbox, Rebecca, Richardson, Jaineeta, Clarke, Gemma, Lister, Michelle, Howson-Wells, Hannah C, Fleming, Vicki M, Khakh, Manjinder, Sloan, Tim, Duckworth, Nichola, Walsh, Sarah, Denning, Chris, McClure, C Patrick, Benest, Andrew V, Seedhouse, Claire H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The COVID-19 pandemic, which began in 2020 is testing economic resilience and surge capacity of healthcare providers worldwide. At the time of writing, positive detection of the SARS-CoV-2 virus remains the only method for diagnosing COVID-19 infection. Rapid upscaling of national SARS-CoV-2 genome testing presented challenges: (1) Unpredictable supply chains of reagents and kits for virus inactivation, RNA extraction and PCR-detection of viral genomes. (2) Rapid time to result of
ISSN:0022-2615
1473-5644
DOI:10.1099/jmm.0.001301